To validate the expression changes of these prognostic signature genes in patients with DLBCL, we collected 7 clinical samples of DLBCL and detected the mRNA expression of these four genes (TUBB4A, SLC38A5, S100B, and TEX9) using qRT-PCR. Here, SLC38A5 is linked to diffuse large B-cell lymphoma.